Skip to main content
. 2016 Oct 19;11:2625–2632. doi: 10.2147/COPD.S118523

Table 2.

Annual direct and indirect costs per patient for COPD, RMB Yuan (US$)

Beijing Guangzhou Shanghai Chengdu Total
Direct costs 7,870 (16,462±28,746) 3,773 (12,739±28,068) 6,288 (11,254±15,355) 7,071 (9,897±14,462) 6,096 (12,614±22,892)
(1,218 [2,549±4,451]) (584 [1,972±4,346]) (974 [1,742±2,377]) (1,095 [1,532±2,239]) (944 [1,953±3,544])
 Direct medical costs 6,824 (15,519±28,396) 3,178 (12,451±27,501) 5,214 (10,235±14,628) 6,628 (9,571±14,376) 5,565 (11,968±22,422)
(1,057 [2,403±4,396]) (492 [1,928±4,258]) (807 [1,585±2,265]) (1,026 [1,482±2,226]) (862 [1,853±3,472])
 Outpatient costs 2,939 (6,480±15,748) 1,328 (2,856±3,630) 2,598 (4,670±8,339) 0 (854±3,456) 1,278 (3,730±9,481)
(455 [1,003±2,438]) (206 [442±562]) (402 [723±1,291]) (0 [132±535]) (198 [578±1,468])
 Outpatient costs per visit 434 (598±901) 190 (278±377) 212 (298±300) 0 (97±343) 156 (319±567)
(67 [93±139]) (29 [43±58]) (33 [46±46]) (0 [15±53]) (24 [49±88])
 Hospitalization costs 0 (9,039±24,197) 0 (9,649±27,611) 0 (5,565±12,429) 6,397 (8,717±13,803) 0 (8,255±20,967)
(0 [1,399±3,746]) (0 [1,494±4,275]) (0 [862±1,924]) (990 [1,350±2,137]) (0 [1,278±3,246])
 Hospitalization costs per visit 0 (6,120±17,754) 0 (3,938±8,317) 0 (3,171±5,644) 3,695 (5,001±7,824) 0 (4,554±10,972)
(0 [948±2,749]) (0 [610±1,288]) (0 [491±874]) (572 [774±1,211]) (0 [705±1,699])
 Direct nonmedical costs 30 (680±1,378) 0 (308±1061) 0 (848±3,691) 0 (334±1,011) 0 (539±2,092)
(5 [105±213]) (0 [48±164]) (0 [131±571]) (0 [52±157]) (0 [83±324])
 Nutrition costs 0 (279±561) 0 (233±781) 0 (719±3,687) 0 (142±541) 0 (341±1,914)
(0 [43±87]) (0 [36±121]) (0 [111±571]) (0 [22±84]) (0 [53±296])
 Caregiver costs 0 (335±984) 0 (59±458) 0 (85±306) 0 (188±856) 0 (166±718)
(0 [52±152]) (0 [9±71]) (0 [13±47]) (0 [29±133]) (0 [26±111])
 Transportation costs 1 (67±114) 0 (16±140) 0 (44±85) 0 (5±22) 0 (33±104)
(0 [10±18]) (0 [2±22]) (0 [7±13]) (0 [1±3]) (0 [5±16])
Indirect costs 0 (5,737±12,532) 0 (558±3,135) 0 (1,456±8,436) 0 (614±3,058) 0 (2,087±8,110)
(0 [888±1,940]) (0 [86±485]) (0 [225±1,306]) (0 [95±473]) (0 [323±1,256])
 Due to patient 0 (2,191±6,228) 0 (52±557) 0 (882±7,958) 0 (275±2,647) 0 (843±5,240)
(0 [339±964]) (0 [8±86]) (0 [137±1,232]) (0 [43±410]) (0 [131±811])
 Work loss, days 0 (8.4±6.0) 0 (0.3±0.9) 0 (3.3±7.5) 0 (2.1±5.1) 0 (3.5±5.4)
(0 [8.4±6.0]) (0 [0.3±0.9]) (0 [3.3±7.5]) (0 [2.1±5.1]) (0 [3.5±5.4])
 Due to family 0 (3,567±9,739) 0 (506±2,998) 0 (578±2,984) 0 (339±1,591) 0 (1,247±5,522)
(0 [552±1,508]) (0 [78±464]) (0 [89±462]) (0 [52±246]) (0 [193±855])
 Work loss, days 0 (13.7±9.3) 0 (3.1±4.6) 0 (2.2±2.8) 0 (2.6±3.1) 0 (5.4±5.7)
(0 [13.7±9.3]) (0 [3.1±4.6]) (0 [2.2±2.8]) (0 [2.6±3.1]) (0 [5.4±5.7])
Total 11,038 (22,199±35,174) 3,773 (13,277±28,759) 6,473 (12,676±17,623) 7,200 (10,510±14,934) 6,405 (14,695±25,942)
(1,709 [3,437±5,446]) (584 [2,056±4,453]) (1,002 [1,963±2,729]) (1,115 [1,627±2,312]) (992 [2,275±4,017])

Notes: Data were presented as median (mean ± standard deviation). Kruskal–Wallis or Wilcoxon test was used to test the differences of costs among groups.

Abbreviation: COPD, chronic obstructive pulmonary disease.